Susquehanna Portfolio Strategies »

4d Molecular Therapeutics In shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2025-12-31 $77k 10k 7.50

More positions owned by Susquehanna Portfolio Strategies

Merck & Co (MRK)
Micron Technology (MU)
Apple (AAPL)
General Motors Company (GM)
Oracle Corporation (ORCL)
Philip Morris International (PM)
Pfizer (PFE)
Blackrock (BLK)
Amazon (AMZN)
TJX Companies (TJX)
Costco Wholesale Corporation (COST)
McDonald's Corporation (MCD)
Arista Networks Com Shs (ANET)
American Express Company (AXP)
Simon Property (SPG)

View all positions for Susquehanna Portfolio Strategies

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In